Product Information
REPAGLINIDE 0.5 MG TABLET is a generic product labeled by NorthStar Rx LLC, priced at $0.0761 per EA under NDC 72603081001. Its NADAC has been published 35 times since Oct 29, 2025.
Strength
.5 mg/1
Manufacturer
NorthStar Rx LLCNDC
72603081001
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
REPAGLINIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207209On Market Since
4/8/2025
Pharmacological Classes
Price Statistics
The NADAC for REPAGLINIDE 0.5 MG TABLET has been published 35 times since Oct 29, 2025, and over the history we have for it it has declined 14.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0761 per EA |
|---|---|
| All-time high | $0.0890 (Nov 12, 2025) |
| All-time low | $0.0723 (Dec 17, 2025) |
| 52-week high | $0.0890 |
| 52-week low | $0.0723 |
| Median price | $0.0794 |
| Average price | $0.0791 |
| Largest weekly change | -10.7% (Nov 19, 2025) |
| Weeks tracked | 35 |
| Tracking since | Oct 29, 2025 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of REPAGLINIDE 0.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for REPAGLINIDE 0.5 MG TABLET, manufactured by NorthStar Rx LLC, is $0.0761 per EA (NDC 72603081001), effective Jun 24, 2026.
How has the price of REPAGLINIDE 0.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for REPAGLINIDE 0.5 MG TABLET has declined 14.5%. It has been tracked across 35 weekly CMS publications since Oct 29, 2025.
What are the highest and lowest recorded NADAC prices for REPAGLINIDE 0.5 MG TABLET?
Since Oct 29, 2025, the NADAC for REPAGLINIDE 0.5 MG TABLET has ranged from a low of $0.0723 (Dec 17, 2025) to a high of $0.0890 (Nov 12, 2025), with a median of $0.0794 per EA.
Are there cheaper alternatives to REPAGLINIDE 0.5 MG TABLET?
4 NADAC-published products share the same active ingredient, strength, and dosage form as REPAGLINIDE 0.5 MG TABLET, but none are currently priced below it.
Who manufactures REPAGLINIDE 0.5 MG TABLET?
REPAGLINIDE 0.5 MG TABLET (NDC 72603081001) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification